VIM and prostate cancer: Additionally, the isolation of purely mesenchymal tumor cells from a model of prostate cancer shows that these Vimentin positive cells showed reduced capacity to form metastatic lesions upon tail vein injection when compared with their Vimentin negative counterparts[39].